Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Candidate Scaffolds for the Treatment of Stress Urinary Incontinence: A Narrative Review.

Isali I., Khanmammadova N., Ozcelik C., Wong TR., Shen D.

Narrative Review on Chronic Inflammation, published in Neurourol Urodyn (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Neurourol Urodyn (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40581871
DOI
10.1002/nau.70095

Abstract (original English)

Aims Biodegradable scaffolds have emerged as a promising alternative to polypropylene (PP) meshes for the treatment of stress urinary incontinence (SUI) due to their biocompatibility and potential for tissue regeneration. Methods A narrative review was conducted focusing on articles published within the last 10 years. Results Polymeric materials such as small intestinal submucosa (SIS), poly(lactic acid) (PLA), poly(Chitosan-g-lactic Acid) (PCLA), poly(glycolic acid) (PGA), and poly(lactic-co-glycolic acid) (PLGA) have been explored for their ability to provide mechanical support, facilitate tissue repair, and degrade in a controlled manner. Each material offers unique advantages, such as SIS's enhanced biocompatibility, PLA's mechanical strength, and PGA's rapid degradation. However, challenges remain in optimizing these materials for clinical use, including controlling degradation rates, minimizing inflammatory responses, and addressing issues related to scaffolds' mechanical properties. Moreover, integrating adipose-derived stem cells (ADSCs) has shown promise in enhancing tissue regeneration and angiogenesis. The primary obstacles preventing clinical implementation have been premature scaffold degradation before adequate tissue ingrowth and insufficient tensile strength in dynamic pelvic environments. Conclusions This review discusses the current state of biodegradable scaf

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansUrinary Incontinence, StressTissue ScaffoldsAnimalsAbsorbable ImplantsBiocompatible MaterialsTreatment OutcomePolymersPolyesters

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research